Ischemic insults promote epigenetic reprogramming of {micro} opioid receptor expression

Mu-opioid Receptors Facilitate the Propagation of Excitatory Activity in Rat Hippocampal Area CA1 by Disinhibition of all Anatomical Layers A. Rory McQuiston and Peter Saggau

J Neurophysiol 90:1936-1948, 2003. First published 15 May 2003; doi: 10.1152/jn.01150.2002 You might find this additional info useful... This article cites 68 articles, 29 of which you can access for free at: http://jn.physiology.org/content/90/3/1936.full#ref-list-1 This article has been cited by 6 other HighWire-hosted articles: http://jn.physiology.org/content/90/3/1936#cited-by Updated information and services including high resolution figures, can be found at: http://jn.physiology.org/content/90/3/1936.full

This information is current as of May 30, 2013.

Journal of Neurophysiology publishes original articles on the function of the nervous system. It is published 12 times a year (monthly) by the American Physiological Society, 9650 Rockville Pike, Bethesda MD 20814-3991. Copyright © 2003 by the American Physiological Society. ISSN: 0022-3077, ESSN: 1522-1598. Visit our website at http://www.the-aps.org/.

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

Additional material and information about Journal of Neurophysiology can be found at: http://www.the-aps.org/publications/jn

J Neurophysiol 90: 1936 –1948, 2003. First published May 15, 2003; 10.1152/jn.01150.2002.

Mu-opioid Receptors Facilitate the Propagation of Excitatory Activity in Rat Hippocampal Area CA1 by Disinhibition of all Anatomical Layers A. Rory McQuiston and Peter Saggau Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030 Submitted 20 December 2002; accepted in final form 7 May 2003

The sole receptor subtype responsible for the addictive properties of opioids appears to be the ␮-opioid receptor (MOR) (Matthes et al. 1996). Inhibition of MORs, but not other opioid receptor subtypes, decreases self-administration of opiates and conditioned place preference for opiate administration in laboratory animals (Matthes et al. 1996; Negus et al. 1993). Interestingly, hippocampal ablation also disrupts conditioned place preference for systemically administered morphine (Olmstead and Franklin 1997a), and morphine injected directly into the hippocampus can induce conditioned place preference in rats (Corrigall and Linseman 1988). Together, these findings suggest that the activation of MORs in the hippocampus may

contribute to the formation of associations between environmental cues and drug use, and that MORs in the hippocampus may play an important role in the expression of addictive behavior. Therefore it is important to understand how MOR activity affects neuronal network function in the hippocampus. Inhibitory interneurons (primarily GABAergic) are very diverse in structure and function (Freund and Buzsaki 1996). MORs are found almost exclusively on inhibitory interneurons in area CA1 (Arvidsson et al. 1995; Bausch and Chavkin 1995; Drake and Milner 1999, 2002; Mansour et al. 1995), but not all subtypes of interneurons express MORs (Drake and Milner 2002). Autoradiographic studies have localized MORs to the pyramidal cell layer, suggesting a selective action of MORs on synaptic inhibition onto the somata of pyramidal cells (Crain et al. 1986; Mansour et al. 1987; McLean et al. 1987). However, immunohistochemistry has localized MOR1 to interneuron subtypes that synapse on the perisomatic region and on the distal dendrites of CA1 pyramidal cells (Drake and Milner 2002), suggesting that MOR activation may modulate synaptic inhibition onto both pyramidal cell bodies and their distal dendrites. Therefore MOR activation in CA1 of the hippocampus appears to modulate synaptic inhibition onto pyramidal cell bodies, although their function in the dendrites is less clear. The differential expression of MORs on selective subtypes of interneurons is supported by physiological studies. Activation of MORs has been shown to hyperpolarize interneurons (Madison and Nicoll 1988; Svoboda and Lupica 1998; Svoboda et al. 1999; Wimpey and Chavkin 1991) and presynaptically inhibit the release of GABA (Capogna et al. 1993; Cohen et al. 1992; Lupica 1995; Lupica et al. 1992; Masukawa and Prince 1982; Nicoll et al. 1980; Rekling 1993). More specifically, MOR-induced hyperpolarizations were more frequently observed in stratum oriens (SO) interneurons that targeted the pyramidal cell body layer than in interneurons projecting to their dendrites (Svoboda et al. 1999). These authors interpreted this observation to be consistent with previous extracellular electrophysiological studies that described an MOR-induced increase in the excitability of pyramidal cells’ somata, with no concomitant effect on excitatory inputs to their dendrites (Corrigall and Linseman 1980; Dingledine 1981; Haas and Ryall 1980; Lee et al. 1980; Lynch et al. 1981; Martinez et al. 1979; Zieglgansberger et al. 1979). Furthermore, discrete application of opioid agonists to the cell body region of CA1 produced a

Address for reprint requests: P. Saggau, Division of Neuroscience, Baylor College of Medicine, One Baylor Plaza S-603, Houston, TX, 77030 (E-mail: [email protected]).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

INTRODUCTION

1936

0022-3077/03 $5.00 Copyright © 2003 The American Physiological Society

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

McQuiston, A. Rory and Peter Saggau. MORs facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers. J Neurophysiol 90: 1936 –1948, 2003. First published May 15, 2003; 10.1152/jn.01150.2002. Hippocampal ␮-opioid receptors (MORs) have been implicated in memory formation associated with opiate drug abuse. MORs modulate hippocampal synaptic plasticity acutely, when chronically activated, and during drug withdrawal. At the network level, MORs increase excitability in area CA1 by disinhibiting pyramidal cells. The precise inhibitory interneuron subtypes affected by MOR activation are unknown; however, not all subtypes are inhibited, and specific interneuron subtypes have been shown to preferentially express MORs. Here we investigate, using voltage-sensitive dye imaging in brain slices, the effect of MOR activation on the patterns of inhibition and on the propagation of excitatory activity in rat hippocampal CA1. MOR activation augments excitatory activity evoked by stimulating inputs in stratum oriens [i.e., Schaffer collateral and commissural pathway (SCC) and antidromic], stratum radiatum (i.e., SCC), and stratum lacunosummoleculare (SLM; i.e., perforant path and thalamus). The augmented excitatory activity is further facilitated as it propagates through the CA1 network. This was observed as a proportionately larger increase in amplitudes of excitatory activity at sites distal from where the activity was evoked. This facilitation was observed for excitatory activity propagating from all three stimulation sites. The augmentation and facilitation were prevented by GABAA receptor antagonists (bicuculline, 30 ␮M), but not by GABAB receptor antagonists (CGP 55845, 10 ␮M). Furthermore, MOR activation inhibited IPSPs in all layers of area CA1. These findings suggest that MOR-induced suppression of GABA release onto GABAA receptors augments all inputs to CA1 pyramidal cells and facilitates the propagation of excitatory activity through the network of area CA1.

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

larger and more consistent increase in pyramidal cell body excitability, than application to the apical dendrites (Dingledine 1981; Robinson and Deadwyler 1981). Taken together, previous physiological studies suggest that MORs act to selectively inhibit the release of GABA onto CA1 pyramidal cell somata, resulting in an increase cell body excitability and output, while having little influence on inputs and synaptic integration in their dendrites. Although most physiological studies suggest that MORs act to selectively inhibit the release of GABA onto pyramidal cell somata, the anatomical data are less consistent as to the relative effect of MORs on pyramidal cell somata versus their distal dendrites. To determine if MOR activation significantly affects synaptic inhibition in the dendrites, we investigated the influence of MOR activity on the network properties, excitatory inputs, synaptic inhibition, and synaptic integration in hippocampal area CA1 using voltage-sensitive dye imaging.

Young male Sprague–Dawley rats (3–7 wk old) were anesthetized with halothane, followed by an ip injection of ketamine/xylazine. Once the animals were deeply anesthetized, they were transcardially perfused through the left ventricle with ice cold saline (30 – 40 ml) consisting of (in mM) 230 sucrose, 2.5 KCl, 1 CaCl, 4 MgCl2, 1 NaHPO4, 25 NaHCO3, and 10 glucose. The animals were then decapitated and their brains were removed. The brain was hemisected, and the most rostral portion of the brain cut and glued down to the stage of a Vibratome 1000 plus (TPI, St. Louis, MO). Coronal sections (350 ␮m) of the hemisected brain were cut in sucrose saline, held in a holding chamber at 30°C for 30 min, and allowed to adjust to room temperature. Brain slices were maintained in a holding solution consisting of (in mM) 125 NaCl, 3.0 KCl, 2 CaCl, 6 MgCl2, 1 NaHPO4, 25 NaHCO3, and 10 glucose, until used in experiments. Harvesting of brain tissue was performed in accordance with the guidelines of the National Institutes of Health, as approved by the animal care and use committee of Baylor College of Medicine. Slices from the mid- to temporal hippocampus were used in these experiments. Individual slices were transferred to a staining chamber containing 25 ␮M of the voltage-sensitive dye (VSD) RH-795 diluted in the holding solution. This dilution was made from a 2.5 mM stock solution of RH-795, dissolved in water, and stored at 4°C for less than a week. The brain slices were stained for 30 min, placed back in the holding chamber for 5 min, then perfused in the recording chamber for 15 min before performing experiments to permit the removal of excess dye. The stained hippocampal slice was imaged from beneath through the glass coverslip bottom of the recording chamber that was mounted on the stage of a Zeiss IM35 inverted microscope (Thornwood, NY). The transilluminated real-time image of the slice was captured with a frame grabber connected to a CCD camera and displayed on a computer monitor. This permitted the placement of tungsten bipolar stimulating electrodes (FHC, Bowdoinham, Maine) either in the SO, stratum radiatum (SR), or stratum lacunosum-moleculare (SLM) to evoke synaptic potentials from specific anatomical inputs. In some experiments, cuts in the slices were made to isolate specific inputs to the CA1 pyramidal cells. Synaptic events were evoked by 100-␮s current pulses of 20 –100 ␮A. Stimulation strength was adjusted to produce approximately a 50% maximal response. Stimulation occurred 60 and 110 ms after the beginning of every record. Individual records lasted 300 ms. During experiments, brain slices were continuously perfused in a submerged recording chamber with saline consisting of (in mM) 125 NaCl, 3.0 KCl, 2 CaCl, 2 MgCl2, 1 NaHPO4, 25 NaHCO3, and 10 glucose, either at room temperature or 30°C. All J Neurophysiol • VOL

examples in the results are taken from experiments performed at room temperature (approximately 22°C). Details of the VSD imaging have been described previously (Colom and Saggau 1994; Sinha et al. 1995; for review: Sinha and Saggau 1999) and will be mentioned here briefly. Brain slices stained with RH-795 were illuminated with a tungsten-halogen light source (12 V, 100 W, Xenophot HLX Osram-Sylvania, Danvers, MA) using a stable power supply (Kepco ATE 75– 8M, Flushing, NY). A 10 ⫻ 0.5 NA objective lens (Nikon, Melville, NY) focused the excitation light on the region of interest of hippocampal area CA1. Excitation light passed through a 535/50 nm band-pass filter and was reflected by a 605-nm dichroic beamsplitter into the back focal aperture of the objective to illuminate the slice. Emitted fluorescent light was collected by the same objective, passed through the dichroic beamsplitter, and through a 610-nm long pass filter. The filters and dichroic beamsplitter were purchased from Chroma (Brattleboro, CT). An image of the region of interest was focused on a photodiode array (10 ⫻ 10 elements; MD-100, Centronics, Newbury Park, CA), and a custom-made 100-channel current-to-voltage converter and amplifier was used to quantitatively measure the fluorescent light. The data were displayed as the change in fluorescence divided by the resting fluorescence (⌬F/F). This eliminates variations in the signal due to differences in dye concentration, illumination intensity, sensitivity of the photodiode elements, and bleaching that occurred as the experiments progressed. The signals were sampled at 2 kHz per channel and filtered with a 10-point moving box filter. A depolarization of membrane potential produces a reduction in ⌬F/F, or a downward deflection. Therefore to be consistent with electrophysiological conventions, ⌬F/F signals were inverted so that depolarizations were displayed as upward deflections. Optical signals were either shown as traces (averages of adjacent photodiode signals that collected signals from the same anatomical layer) or color-coded images of the ⌬F/F signals from the entire photodiode array. VSD signals were quantified by measuring the peak amplitudes of the first and second excitatory postsynaptic potential (EPSP) or inhibitory postsynaptic potential (IPSP) and the area (relative to baseline) of both synaptic events. To make comparisons of a drug’s effect between anatomical layers, the changes in amplitudes and areas were normalized to the control values for each layer [i.e., (Drug ⫺ Control)/Control]. Values were reported as mean ⫾ SE. For data with paired measurements, statistical significances were determined using a repeated measures ANOVA. For unpaired data, statistical significances were examined using a one-way ANOVA. 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium (NBQX), D-2-amino-5-phosphonovaleric acid (APV), (–)-bicuculline methochloride (BIC), CGP 55845, [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAGO), naloxonazine dihydrochloride, and naloxone were all purchased from Tocris Cookson (Ellisville, MO). All other compounds were purchased from Fisher Scientific (Houston, TX). RESULTS

We used optical imaging with a VSD and a photodiode array to examine the modulatory effect of MOR activation on the propagation of excitatory activity in the neuronal network of rat hippocampal area CA1. To do this, we placed bipolar stimulating electrodes in three different excitatory afferent pathways of CA1: in the SLM, to determine the effect of MOR activation on inputs from the entorhinal cortex and thalamus; in the SR, to examine the effect of MOR activation on the Schaffer collateral and commissural (SCC) inputs from CA3 onto CA1 pyramidal cell apical dendrites; and in the SO, to examine the effect of MOR activation on the SCC inputs onto the CA1 pyramidal cell basal dendrites and back propagating action potentials (AP) into the apical dendrites of CA1 pyra-

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

METHODS

1937

1938

A. R. MCQUISTON AND P. SAGGAU

peared to result from the activation of a number of different types of receptors. The delayed depolarization was inhibited by both glutamatergic and GABAA receptor antagonists suggesting that activation of both of these receptor types contributed to the depolarization (Fig. 1Aii). Interestingly, the pseudo-color image shows that the delayed depolarization persisted in SLM while IPSPs were observed in other portions of CA1 (SO, stratum pyramidale (SP), and SR; Fig. 1B). Thus consistent with previous studies, these observations suggest that we measured synaptically driven membrane potential changes from a population of nerve cells imaged onto the photodiode detectors (Jin et al. 2002; Sinha et al. 1995; for review see Zochowski et al. 2000). We investigated the effect of MOR activation on the different types of excitatory input to CA1 and how MOR activity affected the spread of excitatory activity in the network of CA1. Only results in which the MOR antagonists naloxone (5 ␮M) or naloxonazine (5 ␮M) reversed the effects of MOR agonists at the end of each experiment were included for analysis. MOR activation facilitates the propagation of excitatory activity from SLM inputs Paired-pulse stimulation of afferents in SLM (perforant path and thalamus; Fig. 2Ai) produced VSD signals reminiscent of EPSPs (Fig. 2Aii). This excitatory activity degraded in ampliFIG. 1. Stimulation of synaptic inputs to hippocampal CA1 produces excitatory activity and inhibitory postsynaptic potentials (IPSPs) in all anatomical layers. Ai: image of the region of the hippocampal CA1 slice used for voltage-sensitive dye (VSD) measurements. Arrowhead indicates the placement of the stimulating electrodes. Color-coded boxes show the individual photodiodes averaged to produce ⌬F/F traces (Aii) for each layer in the slice. SO, green; SP, blue; SR, red; SLM, gold. Box dimension was 141 ⫻ 141 ␮m2. Aii: representative VSD ⌬F/F traces for each layer. Electrical stimulation (60 and 110 ms) [rounded black arrowheads in stratum radiatum (SR) panel] produced depolarizing events that decay in amplitude as they propagate toward stratum oriens (SO) (black). Excitatory events were superimposed on hyperpolarizations in each layer. A delayed depolarization was restricted to stratum lacunosum-moleculare (SLM). Glutamate receptor antagonists (NBQX 30 ␮M, APV 50 ␮M) reduced excitatory event amplitudes and durations in all layers leaving short-duration smaller amplitude depolarizations superimposed on hyperpolarizations (blue). NBQX and APV reduced the late depolarization in SLM. GABAA receptor antagonist (bicuculline, 30 ␮M, BIC) inhibited the hyperpolarization in all layers (orange). BIC also inhibited the late depolarization in SLM (arrow). Scale bars horizontal 50 ms, vertical 0.01% ⌬F/F. B: pseudo-color images of excitatory activity evoked by electrical stimulation in SLM (dot). Thin lines indicate borders of individual anatomical layers of Ai. Asterisks signify times of stimulation. Initially, excitatory activity (red/yellow) propagated from SLM into SR and along SLM. Hyperpolarizations (dark green/blue) were observed in SR, SP, and SO after the 1st stimulation and immediately before the 2nd stimulation (110 ms, *). The 2nd pulse produces excitatory activity confined to SLM. A delayed hyperpolarization is observed in SR, SP, and SO at the same time a depolarization continues to occur in SLM (140 ms and later). Ci: image of the region of the hippocampal CA1 slice used for VSD measurements. For parameters see Ai. Cii: electrical stimulation in SR (60 and 110 ms, arrowhead) produced depolarizations superimposed on hyperpolarizations (black). Excitatory activity was blocked by glutamate receptor antagonists (NBQX, 30 ␮M and APV, 50 ␮M). leaving small IPSP-like hyperpolarizations in SR, SP, and SO (blue). Bicuculline (30 ␮M) inhibited the hyperpolarizations (orange). Scale bars are: horizontal 50 ms, vertical 0.013% ⌬F/F.

J Neurophysiol • VOL

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

midal cells. Stimulation consisted of paired current pulses (100 ␮s, 20 –100 ␮A) delivered 60 and 110 ms after the beginning of an individual trace (300 ms duration). Due to the nature of VSDs, stimulation resulted in optical signals that are similar to EPSPs and IPSPs measured by intracellular electrophysiological methods (Fig. 1) (Jin et al. 2002; Sinha et al. 1995). Consistent with the VSD signals arising from synaptic potentials, the VSD signals were inhibited by ionotropic glutamate and GABA receptor antagonists (Fig. 1C). Occasionally fast depolarizing VSD signals were observed (approximately 6 ms in duration at the base) in the presence of glutamate and GABA receptor blockers, and this presynaptic activity was discernible from the postsynaptic events (Fig. 1A). The fast signals could be blocked by tetrodotoxin (1 ␮M; data not shown). Although glutamatergic antagonists inhibited the depolarizing signals, suggesting that they arise from the activation of EPSPs, these signals may include contributions from the activation of voltage-dependent ion channels and asynchronous action potentials. Therefore rather than calling these synaptically evoked depolarizations EPSPs, we shall refer to these depolarizations as excitatory activity or excitatory events. The hyperpolarizing potentials on the other hand were completely blocked by GABAA antagonists, suggesting that they were IPSPs. In addition to EPSP-like excitatory activity and IPSPs, stimulation in SLM produced a slow delayed depolarization that was confined to SLM (Fig. 1Aii). This delayed depolarization ap-

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

1939

A

B

C

D

tude as it propagated away from the site of stimulation (from SLM via SR and SP to SO). IPSPs were also observed in some layers (Fig. 2Aii, SP and SO). The amplitude of the excitatory activity was increased in all anatomical layers by the MOR agonist DAGO (Fig. 2Aii). The amount of augmentation of the excitatory activity amplitude is best observed in the subtraction of the control signal from the signal in DAGO (Fig. 2Aii). In addition to fast excitatory events, stimulation in the SLM produced a delayed depolarization that was restricted to SLM. In contrast to the augmentation of the initial excitatory events, DAGO inhibited the delayed depolarization in SLM (Fig. 2Aii, amplitude ⫺33 ⫾ 5%, P ⬍ 0.001; area ⫺28 ⫾ 2%, P ⬍ 0.0001, n ⫽ 9). J Neurophysiol • VOL

The pseudo-color images illustrate the spatial and temporal effects of DAGO on excitatory activity arising from inputs in SLM (Fig. 2B). DAGO produced an increase in the amplitude of the first excitatory event amplitude in SLM (60 ms) and in the layers that it propagated through (SR, SP, and SO). DAGO also increased the amplitude of the second excitatory event (110 ms) in all layers. Interestingly, while there was an inhibition of the late depolarization in SLM, the excitatory activity continued to be augmented in the outputs layers (SP and SO; at 190 –250 ms; Fig. 2B). To compare the effect of DAGO on the excitatory activity across anatomical layers, the difference between the control signals and the signals in DAGO were normalized for each

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 2. SLM-evoked excitatory activity is increased in all anatomical layers of CA1. Ai: bright field image of the hippocampal slice. Arrowhead points to stimulation site in SLM. Color-coded boxes in different layers show individual photodiodes used for ⌬F/F signals in Aii and Ci. SO, green; SP, blue; SR, red; SLM, gold. Box dimensions were 141 ⫻ 141 ␮m2. Aii: representative VSD ⌬F/F traces for each layer. Excitatory postsynaptic potential (EPSP) amplitudes (evoked at 60 and 110 ms) decreased as EPSPs propagated from SLM to SO (black). DAGO (2 ␮M) increased amplitude of EPSPs in all layers (blue). Difference between control EPSP and EPSP in DAGO (DAGO ⫺ Control) are shown in orange. Note, late depolarization in SLM was not augmented, but was inhibited by DAGO (arrow). Naloxone (5 ␮M) inhibited the effect of DAGO (yellow). Scale bars: vertical 0.012% ⌬F/F, horizontal 50 ms. B: pseudo-color images of difference between control EPSPs and DAGO EPSPs, (DAGO ⫺ Control). Thin lines indicate borders of individual anatomical layers of Ai, dot shows stimulation site. Asterisks signify time of stimulation. Initially, DAGO (2 ␮M) produced an augmentation of EPSP (yellow/red) around stimulation site (small dot), followed by an augmentation in output layers SP/SO. Note later (⬎190 ms), DAGO inhibited late depolarization in SLM (blue) and simultaneously augmented activity (yellow/ red) in output layers (SO/SP). C: normalization of DAGOinduced augmentation of EPSPs, [(DAGO ⫺ Control)/Control], for each individual photodiode in the array, in the different anatomical layers. Ci: note, DAGO increased EPSPs to a relatively greater extent as they moved from site of initiation (SLM, gold), through network (SR, red), to output regions (SO, green/SP, blue). Scale bars: vertical 23% of control, horizontal 50 ms (Cii–Civ). Histograms of DAGOinduced augmentation of EPSPs in different anatomical layers, expressed as percentage of control EPSPs [100 ⫻ (DAGO ⫺ Control)/Control]. DAGO-induced augmentation of 1st EPSP amplitude (Ciii), 2nd EPSP amplitude (Civ), and total EPSP area (Cii) showed a significant difference between anatomical layers [repeated measures ANOVA, P ⬍ 0.01 (amplitude 1), P ⬍ 0.05 (amplitude 2), P ⬍ 0.05 (area)]. Post hoc analysis showed a significant trend to a larger percent augmentation of EPSPs as they moved away from stimulation site (SLM) to output layers of CA1 (SO/SP) [post-test for linear trend, P ⬍ 0.001 (amplitude 1), P ⬍ 0.01 (amplitude 2), P ⬍ 0.01 (area)]. D: pseudo-color image of normalized DAGO-induced augmentation of EPSPs. Normalization of change in EPSP shows largest relative DAGO-induced augmentation (red) of EPSP occurred away from stimulation site, near proximal apical dendrites in SR, SP, and SO.

1940

A. R. MCQUISTON AND P. SAGGAU

MOR activation facilitates the propagation of excitatory activity from SR inputs We also tested whether MOR activity modulated SCC afferents in SR. Similar to the observations in SLM, excitatory activity generated in SR (Fig. 3Aii) diminished in amplitude as it propagated away from the site of stimulation (from SR to SLM and SR to SP/SO). In addition to excitatory activity, IPSPs were observed in some layers (Fig. 3Aii, SO). Excitatory activity in all layers was increased in amplitude by the application of DAGO. Subtraction of the control signals from the signals in DAGO illustrates the amount of augmentation of the excitatory activity (Fig. 3Aii). As for the stimulation in SLM, pseudo-color images show the spatial and temporal extent of the DAGO-induced augmentation of the excitatory activity generated in SR (Fig. 3B). Both of the excitatory events generated in SR (60 and 110 ms) were augmented by DAGO, and this augmentation was also observed in the output layers (SP and SO). However, little activity was observed in SLM in the color plot because of the relatively small amount of propagation of excitatory activity into SLM (see Fig. 3Aii). The relative amount of augmentation increased as the excitatory activity propagated from the site of stimulation (SR) into SLM and into the output layers (SP/SO; Fig. 3Ci). Normalization of the effect of DAGO on excitatory activity amplitudes (Fig. 3C, iii and iv) showed a significant increase in the amount augmentation as the excitatory activity propagated from the J Neurophysiol • VOL

site of stimulation (SR) into SLM and into the output layers (SP/SO). There was no significant difference in the amount that the excitatory activity area was augmented between anatomical layers, although there was a trend to larger changes in the area of excitatory activity at sites distal from the stimulation location. The normalized change in excitatory activity amplitudes is illustrated in the pseudo-color images (Fig. 3D). These images also show that the excitatory activity was augmented to a larger relative extent as it propagated away from the stimulation site (SR) into proximal SLM and to the output layers (SP/SO). Therefore like the afferents in SLM, the SCC excitatory input to SR is augmented by MOR activity. Also similar to SLM, MOR activation facilitated the propagation of excitatory activity away from the site of stimulation in SR. MOR activation facilitates the propagation of excitatory activity from SO inputs To complete the study of the effect of MOR activity on excitatory activity in CA1, we examined the effect of DAGO on excitatory activity generated in SO. Stimulation of afferents in SO (Fig. 4Ai) produced excitatory activity that decreased in amplitude as it propagated away from the site of stimulation (from SO through SP and SR to SLM; Fig. 4Aii). As in SLM and SR, IPSPs were also observed (Fig. 4Aii). The excitatory activity was augmented in all layers by DAGO (Fig. 4Aii). The difference between the excitatory events in the presence and absence of DAGO is shown in Fig. 3Aii (orange traces). Spatially and temporally, DAGO augmented the first (60 ms) and second (110 ms) excitatory events, both of which subsequently propagated to the SR/SLM border (Fig. 4B). However, because of the relatively small propagation into SLM, little activity was observed in this layer. Normalization of the DAGO effect showed that MOR activation produced a larger relative augmentation of excitatory activity, as it propagated from the site of stimulation (SO) to SR and SLM (Fig. 4Ci). Excitatory event amplitudes and area all showed significant differences in the amount of DAGO-induced augmentation between anatomical layers (Fig. 4C). This is shown spatially and temporally in the pseudo-color images (Fig. 4D). Therefore like SLM and SR, excitatory activity in SO is augmented by MOR activation. Furthermore, MOR activation facilitates the propagation of excitatory activity from its site of generation in SO to other anatomical layers. MOR does not facilitate excitatory activity in the presence of GABAA and GABAB antagonists Previous work has shown that in hippocampal CA1, MORs are not localized to pyramidal neurons or excitatory synaptic terminals, but are instead localized to inhibitory interneurons and inhibitory terminals (Bausch and Chavkin 1995; Drake and Milner 1999, 2002; Mansour et al. 1995). Furthermore, studies have shown that MOR activation can hyperpolarize interneurons and inhibit both GABAA and GABAB IPSPs in pyramidal cells (Capogna et al. 1993; Cohen et al. 1992; Lupica 1995; Lupica et al. 1992; Masukawa and Prince 1982; Nicoll et al. 1980; Rekling 1993). Therefore we wanted to determine if blockade of GABAA and GABAB receptors could prevent the DAGO-induced augmentation of excitatory activity. On occasion, blockade of inhibition produced epileptiform activity, and

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

photodiode [i.e., (DAGO ⫺ Control)/Control; Fig. 2C]. Normalization of the effect of DAGO showed a larger relative augmentation of excitatory activity at sites distal (SP/SO) to the site of stimulation (SLM). To quantify the relative differences in the augmentation of excitatory activity between anatomical layers, we measured the amplitude of the excitatory event produced by the first stimulation (amplitude 1; Fig. 2Ciii), the amplitude of the excitatory event produced by the second stimulation (amplitude 2; Fig. 2Civ), and the total area of the two excitatory events combined (area; Fig. 2Cii) in the absence and presence of DAGO. The amount of DAGOinduced augmentation was then expressed as a percentage of the control [i.e., 100 ⫻ (DAGO ⫺ Control)/Control[. Changes in the amplitude of the excitatory activity reflects an effect on the excitability and propagation of the excitatory activity between layers. A change in area reflects not only a change in excitability but is also a measure of a change in inhibition. This is because in some situations inhibition may not affect the amplitude of the excitatory events, but instead may only affect their kinetics (rise and decay time) and thus area. However, the effect of DAGO on the excitatory event amplitudes and area were similar. Excitatory event amplitudes and area all showed a significant increase in the amount of augmentation as the excitatory activity propagated away from the site of stimulation (SLM) to the output layers (SP/SO; Fig. 2C, ii–iv). The pseudo-color image also showed that the excitatory activity was augmented by a larger relative amount at sites distal to the stimulation location (Fig. 2D). Therefore not only does MOR activity augment the excitatory input in SLM, but MOR activity also facilitates the propagation of the excitatory activity through the dendritic tree of CA1 pyramidal cells to the output layers of CA1.

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

1941

these data were not included for analysis. However, the slicing procedure often produced brain slices in which inputs from CA3 were not intact. This often occurred in coronal slices taken from the mid-hippocampus. In general, these hippocampal slices did not produce epileptiform activity in the presence of GABA receptor antagonists. Even in the presence of GABAA and GABAB receptor antagonists [bicuculline (BIC), CGP 55845, respectively], excitatory activity continued to diminish in amplitude as it propagated away from the stimulation site (SLM) through SR to the output layers SP/SO (Fig. 5). The delayed depolarization previously observed in SLM (Figs. 1 and 2) was not observed in the presence of GABA receptor antagonists (compare with Fig. 5iv). Application of DAGO had no effect on the excitatory J Neurophysiol • VOL

activity (Fig. 5). Under the same conditions, stimulating the afferents in SR and SO produced similar results (data not shown). Thus in the presence of GABA antagonists, DAGO produced no significant change in the amplitudes or area of the excitatory activity, regardless of the stimulation site. This suggests that DAGO augments excitatory activity in CA1 through an inhibition of GABA function. MOR facilitation of excitatory activity involves inhibition of GABA release onto GABAA receptors Since the combination of GABAA and GABAB receptor antagonists prevented an effect of MOR activation on excitatory activity, we next determined which GABA receptor sub-

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 3. SR-evoked EPSPs are increased in all anatomical layers of CA1. Ai: image of hippocampal slice. Arrowhead points to stimulation site in SR. Color-coded boxes in different layers show position of individual photodiodes used for ⌬F/F signals in Aii and Ci. SO, green; SP, blue; SR, red; SLM, gold. Box dimensions were 141 ⫻ 141 ␮m2. Aii: representative VSD ⌬F/F traces for each layer. EPSP amplitudes (evoked at 60 and 110 ms) decreased as EPSPs propagated from SR in 2 directions, 1 toward SP/SO and 1 toward SLM (black). DAGO (2 ␮M) increased amplitude of EPSPs in all layers (blue). Difference between control EPSP and EPSP in DAGO (DAGO ⫺ Control) are shown in orange. Scale bars: vertical 0.017% ⌬F/F, horizontal 50 ms. B: pseudo-color image of difference between Control EPSPs and DAGO EPSPs, (DAGO ⫺ Control). Thin lines indicate borders of anatomical layers in Ai. Dot shows stimulation site. Asterisks signify time of stimulation. Initially, DAGO (2 ␮M) produced an augmentation of EPSP (yellow/red) around stimulation site (small dot), followed by an augmentation in distal layers (SO, SP). C: normalization of the change in EPSPs produced by DAGO [(DAGO ⫺ Control)/ Control]. Ci: note, DAGO increased EPSPs to a relatively greater extent as they moved from site of initiation (SR, red) to other anatomical layers (SP blue/SO green, and SLM gold). Scale bars: vertical 29% of Control, horizontal 50 ms (Cii–Civ). Histograms of DAGO-induced augmentation of EPSPs in different anatomical layers, expressed as a percentage of control EPSPs [100 ⫻ (DAGO ⫺ Control)/Control). DAGO-induced increase of 1st EPSP amplitude (Ciii) and 2nd EPSP amplitude showed a significant difference between anatomical layers [repeated measures ANOVA, P ⬍ 0.01 (amplitude 1), P ⬍ 0.001 (amplitude 2)], whereas total area (Cii) did not show a statistical significant difference. Post hoc analysis showed a significant trend to a larger percent augmentation of EPSPs amplitudes as they moved away from stimulation site (SR) into other layers of CA1 (SO, SP, and SLM) [post-test for linear trend, P ⬍ 0.001 (amplitude 1), P ⬍ 0.001 (amplitude 2)]. D: pseudo-color image of normalized DAGO-induced augmentation of EPSPs. Normalization of the change in EPSPs shows that largest relative DAGO-induced augmentation (red) of EPSP occurred away from stimulation site, near output regions SO/SP, and proximal SLM.

1942

A. R. MCQUISTON AND P. SAGGAU

types were involved in the disinhibition by DAGO. In the presence of the GABAB receptor antagonist CGP55845, all GABAergic inhibition in hippocampal slices resulted from the activation of GABAA receptors. Under these conditions, stimulation in SR (Fig. 6Bi) produced excitatory activity and IPSPs in all layers (Fig. 6A). The amplitude of the excitatory activity diminished as it propagated away from the site of stimulation. Subsequent application of DAGO increased the amplitude of the excitatory activity in all layers (Fig. 6A). Normalization of the DAGO-induced augmentation of excitatory activity illustrates that DAGO caused a relatively larger change in the excitatory activity in layers distal (SLM, SP, SO) from the site of stimulation (SR; Fig. 6Bii). Similar findings were observed when the stimulation site was in SO or SLM. In the presence J Neurophysiol • VOL

of CGP 55845, the effects of DAGO on both the excitatory event amplitudes and area were similar to observations made in the absence of GABAB receptor antagonists. When stimulated in SO, both excitatory event amplitudes and area showed significant increases in the amount augmentation in layers distal to the stimulation site (Fig. 6Ci). When stimulating in SR, excitatory event amplitudes showed a significant increase in the amount augmentation at sites distal to the site of stimulation (Fig. 6Cii). However, the augmentation of excitatory activity area did not show a significant difference between layers, although there was a trend toward a larger amount of augmentation at locations distal to the stimulation site. When stimulating in SLM, both excitatory activity amplitudes and area all showed a significant increase in the relative amount

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 4. SO-evoked EPSPs are increased in all layers of CA1. Ai: image of hippocampal slice. Arrowhead points to stimulation site in SO. Color-coded boxes show photodiodes used for ⌬F/F signals in Aii and Ci. SO, green; SP, blue; SR, red; SLM, gold. Box dimensions were 141 ⫻ 141 ␮m2. Aii: representative VSD ⌬F/F traces for each layer. EPSP amplitudes (evoked at 60 and 110 ms) decreased as EPSPs propagated from SO to SR/SLM (black). DAGO (2 ␮M) increased amplitude of EPSPs in all layers (blue). Difference between control EPSP and EPSP in DAGO (DAGO ⫺ Control) are shown in orange. Scale bars: vertical 0.01% ⌬F/F, horizontal 50 ms. B: pseudo-color image of difference between Control EPSPs and DAGO EPSPs (DAGO ⫺ Control). Thin lines show borders of anatomical layers shown in Ai. Dot shows stimulation site. Asterisks signify time of stimulation. Initially, DAGO (2 ␮M) produced augmentation of EPSP (yellow/red) around stimulation site (small dot); followed by an augmentation in distal layers SR/SLM. C: normalization of EPSPs augmented by DAGO [(DAGO ⫺ Control)/Control]. Ci: note, DAGO increased EPSPs to a relatively greater extent as they moved from site of initiation (SO, green) through network (SP, blue) to distal regions (SR, red/SLM, gold). Scale bars: vertical 26% of Control, horizontal 50 ms (Cii–Civ). Histograms of DAGO-induced augmentation of EPSPs in different anatomical layers, expressed as a percentage of the control EPSPs [100% ⫻ (DAGO ⫺ Control)/ Control]. DAGO-induced increase of 1st EPSP amplitude (Ciii), 2nd EPSP amplitude (Civ), and total EPSP area (Cii) showed a significant difference between anatomical layers [repeated measures ANOVA, P ⬍ 0.0001 (amplitude 1), P ⬍ 0.0001 (amplitude 2), P ⬍ 0.05 (area)]. Post hoc analysis showed a significant trend to a larger percent augmentation of EPSPs as they moved away from stimulation site (SO) to distal layers of CA1 (SR/SLM) [post-test for linear trend, P ⬍ 0.0001 (amplitude 1), P ⬍ 0.0001 (amplitude 2), P ⬍ 0.01 (area)]. D: pseudo-color image of normalized DAGO-induced augmentation of EPSPs. Normalization of the change in EPSPs shows largest relative DAGO-induced augmentation (red) of EPSP occurred away from stimulation site, near distal apical dendrites in SR and proximal SLM.

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

1943

MOR facilitation of excitatory activity does not involve inhibition of GABA release onto GABAB receptors

augmentation as the excitatory activity propagated away from the site of stimulation (SLM; Fig. 6Ciii). Thus in the presence of GABAA receptor inhibition, CA1 excitatory activity is augmented by MOR activation. Therefore the mechanism for the DAGO augmentation of excitatory activity appears to involve the modulation of GABAergic synaptic transmission on to GABAA receptors.

FIG. 6. GABAB receptor antagonist (10 ␮M CGP 55845) does not affect DAGO-induced augmentation of EPSPs. A: representative VSD ⌬F/F traces for each layer. EPSP amplitudes (evoked at 60 and 110 ms, in the presence of CGP 55845; 10 ␮M) decreased as EPSPs propagated away from SR (black). DAGO (2 ␮M) increased amplitude of EPSPs in all layers (blue). Difference between control EPSP and DAGO EPSP (DAGO ⫺ Control) are shown in orange. Scale bars: vertical 0.015% ⌬F/F, horizontal 50 ms. Bi: image of hippocampal slice. Arrowhead points to stimulation site in SR. Color-coded boxes show photodiodes used for ⌬F/F signals in A and Bii. SO, green; SP, blue; SR, red; SLM, gold. Box dimensions were 141 ⫻ 141 ␮m2. Bii: normalization of EPSPs augmented by DAGO [(DAGO ⫺ Control)/Control]. Note, DAGO increased EPSPs to a relatively greater extent as they moved from site of initiation (SR, red). Scale bars: vertical 65% of Control, horizontal 50 ms. C: histograms of normalized effect of DAGO on EPSPs expressed as a percentage of control EPSPs [100 ⫻ (DAGO ⫺ Control)/Control]. Left: DAGO-induced increase of 1st EPSP amplitude. Middle: DAGO-induced increase of 2nd EPSP amplitude. Right: DAGO-induced increase of combined EPSP area. Ci: DAGO-induced augmentation of SO-stimulated EPSPs showed a significant difference between anatomical layers [repeated measures ANOVA P ⬍ 0.05 (amplitude 1), P ⬍ 0.001 (amplitude 2), P ⬍ 0.05 (area)]. Post hoc analysis showed a significant trend to a larger percent augmentation of EPSP amplitudes as they moved away from stimulation site (SO) [post-test for linear trend P ⬍ 0.01 (amplitude 1), P ⬍ 0.0001 (amplitude 2)]. Cii: DAGO-induced augmentation of SR-stimulated EPSPs showed a significant difference between anatomical layers for EPSP amplitudes, but not area [repeated measures ANOVA P ⬍ 0.001 (amplitude 1), P ⬍ 0.05 (amplitude 2)]. Post hoc analysis showed a significant trend to a larger percent increase of EPSPs amplitudes as they moved away from the stimulation site (SR) [posttest for linear trend P ⬍ 0.0001 (amplitude 1), P ⬍ 0.01 (amplitude 2)]. Ciii: DAGO-induced augmentation of SLM-stimulated EPSPs showed a significant difference between anatomical layers [repeated measures ANOVA, P ⬍ 0.0001 (amplitude 1), P ⬍ 0.0001 (amplitude 2), P ⬍ 0.05 (area)]. Post hoc analysis showed a significant trend to a larger percent augmentation of EPSPs as they moved away from stimulation site (SLM) [post-test for linear trend, P ⬍ 0.0001 (amplitude 1), P ⬍ 0.0001 (amplitude 2), P ⬍ 0.01 (area)].

J Neurophysiol • VOL

A

B

C

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 5. GABAA and GABAB antagonists prevent DAGO-induced increase of EPSPs. Extracellular stimulation in SLM, in presence of bicuculline (30 ␮M) and CGP 55845 (10 ␮M), produced decrementing EPSPs (⌬F/F, black) in all anatomical layers of CA1: (i) SO, (ii) SP, (iii) SR, (iv) SLM. Application of DAGO (2 ␮M; in continued presence of bicuculline and CGP55845) did not affect EPSPs in any anatomical layer (blue). There was no statistical difference between Control EPSPs and EPSPs in presence of DAGO (DAGO ⫺ Control, orange; P ⬎ 0.05 for all stimulation sites and all layers, repeated measures ANOVA).

In an attempt to determine if the release of GABA onto GABAB receptors played a role in the mechanism of the DAGO-induced augmentation of excitatory activity, we isolated GABAB receptor inhibition in hippocampal slices by performing experiments in the presence of the GABAA antagonist BIC. Under these conditions, stimulation in SLM produced excitatory activity that declined in amplitude as it propagated away from the site of initiation (SLM) to the output layers (SP/SO; Fig. 7). In contrast to previous observations (Figs. 1Aii and 2Aii), there was no clear late depolarization in SLM in the presence of BIC (Fig. 7iv). In the presence of BIC, DAGO did not increase the size of the excitatory activity (Fig. 7). Similar findings were found when stimulating SO or SR. In the presence of BIC, DAGO did produce a slow late depolarization in some experiments (data not shown); however, the late depolarization was not completely captured within the 300-ms window. A similar observation was made with the GABAB receptor antagonist CGP 55845, but since 300 ms was

1944

A. R. MCQUISTON AND P. SAGGAU

To compare the effect of DAGO on the IPSPs across anatomical layers, the changes in IPSPs were normalized similar to the normalization of the excitatory activity of previous sections. Unlike the excitatory activity, DAGO did not appear to inhibit the IPSPs by a larger relative amount when measured further away from the stimulation electrode (Fig. 8Ci). IPSP amplitudes and area all showed no significant difference in the amount DAGO-induced disinhibition between anatomical layers (Figs. 8C, ii–iv). This is also illustrated spatially and temporally in the pseudo color image (Fig. 8D). Therefore disinhibition of GABA synaptic transmission, by MOR activation, was equivalent in all layers of CA1.

too short a time window, they were not further studied. Under the conditions of these studies, DAGO augmented the excitatory activity independent of inhibiting GABA release onto GABAB receptors. DAGO inhibits IPSPs in all layers of CA1 Because MOR density and differential expression on interneurons in CA1 (Drake and Milner 2002) may affect synaptic inhibition in a layer specific manner (Svoboda et al. 1999), we isolated IPSPs by stimulating afferents in the presence of glutamatergic antagonists (NBQX and APV). Unlike excitatory afferents, inhibitory axons cannot be isolated to an individual anatomical layer as a single axon often innervates more than one anatomical layer (Freund and Buzsaki 1996). Thus stimulation in any given anatomical layer will produce IPSPs in many, if not all CA1 hippocampal layers. Therefore data from stimulation in SO, SR, and SLM were analyzed together. Stimulation in SLM in the presence of glutamate antagonists produced action potentials and IPSPs in all layers (Fig. 8Ai). IPSPs did not degrade in amplitude when measured further away from the stimulation site (Fig. 8Aii). This is consistent with the idea that the IPSPs were not propagating but were due to the release of GABA in all layers. However, IPSPs in SLM were compounded by a late depolarization. Application of DAGO inhibited IPSPs (disinhibition) in all layers (Fig. 8Aii), and inhibited the late depolarization in SLM (Fig. 8Aii, amplitude ⫺42 ⫾ 6%, P ⬍ 0.001; area –52 ⫾ 1%0, P ⬍ 0.01, n ⫽ 7). The portion of the IPSP and the late depolarization inhibited by DAGO is illustrated in the subtraction of the control IPSPs from the IPSPs in the presence of DAGO (Fig. 8Aii). The spatial and temporal pattern of the DAGO-induced inhibition of IPSPs is illustrated in the pseudo-color images in Fig. 8B. The first stimulation (60 ms) produced an inhibition of IPSPs in SR that was subsequently observed in the outer layers (SP and SO). This effect may be the result of a delay in propagation of presynaptic action potentials to their distal release sites. The second stimulation (110 ms) also produced an inhibition of IPSPs in all layers. Interestingly, while there was an inhibition of the late depolarization in SLM, there continued to be an inhibition of IPSPs in the SP and SO (190 –250 ms). J Neurophysiol • VOL

DISCUSSION

The activation of MORs augmented all excitatory inputs to area CA1 of the rat hippocampus (SCC, perforant path, and thalamus). Regardless of the specific excitatory input stimulated (SO, SR, or SLM), the excitatory activity was further facilitated as it propagated through the CA1 network. More specifically, the amount of augmentation of the excitatory activity was larger at locations distant to the stimulation site. The augmentation was exclusively due to the inhibition of GABAergic synaptic transmission onto GABAA receptors. Although MOR activation is known to inhibit GABA release onto GABAB receptors, under the experimental conditions of this study the augmentation of excitatory activity by MOR activation did not involve GABAB receptors. Interestingly, MOR activation reduced GABAergic synaptic transmission in all layers of CA1 by the same amount. We hypothesize that MOR activation continuously augmented excitatory activity as the excitatory event propagated and encountered reduced GABAergic inhibition throughout the CA1 neuronal network. This resulted in larger relative amounts of augmentation of excitatory events at sites distal from the site of stimulation, irrespective of the anatomical site of stimulation. Although excitatory inputs in all layers of CA1 was augmented by MOR activation, the sources contributing to the synaptically evoked depolarization cannot be determined with certainty from these investigations. What we can say is that because the resultant depolarizations are inhibited by postsynaptic glutamatergic receptors antagonists, they must have contributions from EPSPs. Furthermore, they also have similar shapes and kinetics to EPSPs. However, in addition to EPSPs, we cannot discount the possible contribution of voltage-dependent ion channels or action potentials to the amplitude and kinetics of the observed depolarizations. The neuronal source for the depolarizing signals likely arise from excitatory activity produced in pyramidal cells of CA1, as they make up 80 –90% of neurons in CA1 (Freund and Buzsaki 1996). Thus the most likely explanation for the MOR augmentation of the excitatory activity is a disinhibition of synaptically evoked excitation at all inputs to CA1 pyramidal cells. Our findings may appear to be in contrast to previous studies that showed an increase of synaptically driven excitability at the cell body layer without an increase in the EPSP observed in the dendritic layer (Corrigall and Linseman 1980; Dingledine 1981; Haas and Ryall 1980; Lynch et al. 1981; Martinez et al. 1979). However, these dendritic synaptic events were measured using extracellular electrode techniques. This technique does not measure membrane potential changes associated with

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 7. GABAA receptor antagonist prevents augmentation of EPSPs by DAGO. Extracellular stimulation in the SLM, in presence of bicuculline (30 ␮M), produced decrementing EPSPs (⌬F/F, black) in all anatomical layers of CA1: (i) SO, (ii) SP, (iii) SR, (iv) SLM. Application of DAGO (2 ␮M; in continued presence of bicuculline) did not significantly affect EPSPs in any anatomical layer (blue). There was no significant difference between Control EPSPs and EPSPs in the presence of DAGO (DAGO ⫺ Control; orange; P ⬎ 0.05 for all stimulation sites and all layers, repeated measures ANOVA).

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

1945

A

B

C

D

the population EPSP, but instead measures the current flow created by the activation of ligand gated ion channels. While it is sensitive to changes in the number of postsynaptic receptors and the amount of transmitter released, this technique is not sensitive to changes in input resistance or to evoked inhibitory synaptic transmission in the dendrites, both of which could alter EPSP amplitudes. There have been reports of EPSPs of increased duration (Dingledine 1981; Swearengen and Chavkin 1989) due to the unmasking of an N-methyl-D-aspartate (NMDA) component (Swearengen and Chavkin 1989). However, it is not clear that this was due to a disinhibition in the dendrites. The NMDA component occurred 5–10 ms after the population spike appeared in the cell body region and thus the unmasking of the NMDA component could be due to a backpropagating action potential produced in the soma that then J Neurophysiol • VOL

relieved the voltage-dependent block of the NMDA receptors. Therefore it is unclear from previous physiological studies whether MOR activity can disinhibit the dendrites or affect synaptic inputs in the dendrites. However, our studies clarify this issue by demonstrating that MOR activation can increase the amplitude of excitatory synaptic events in the dendrites of CA1 pyramidal cells. In addition to the EPSP-like excitatory events, stimulation of SLM inputs produced a slow delayed depolarization confined to SLM. This delayed depolarization appeared to result from the activation of a number of different processes. The delayed depolarization could be inhibited by both glutamate and GABAA receptor antagonists. The most likely explanation for these findings is that synaptic activation of GABAA receptors caused a depolarization (Cobb et al. 1999; Grover et al. 1993;

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

FIG. 8. DAGO inhibits IPSPs in all layers of CA1. Ai: image of the hippocampal slice. Arrowhead points to stimulation site in SLM. Color-coded boxes show photodiodes used for ⌬F/F signals in Aii and Ci. SO, green; SP, blue; SR, red; SLM, gold. Box dimensions were 141 ⫻ 141 ␮m2. Aii: representative VSD ⌬F/F traces for each layer. Evoked IPSPs were isolated from EPSPs by continuously superfusing slice with ionotropic glutamate receptor antagonists (NBQX, 30 ␮M; APV, 50 ␮M). IPSP amplitudes (black; evoked at 60 and 110 ms) were decreased in presence of 2 ␮M DAGO (blue). Difference between control IPSP and IPSP in DAGO (DAGO ⫺ Control) are shown in orange. Note, late depolarization in SLM was not inhibited by ionotropic glutamate antagonists, but was inhibited by DAGO (arrow). Scale bars: vertical 0.005% ⌬F/F, horizontal 50 ms. B: pseudo-color image of difference between Control IPSPs and DAGO IPSPs (DAGO ⫺ Control). Thin lines show borders of individual anatomical layers shown in Ai and dot stimulation site. Asterisks signify stimulation. DAGO (2 ␮M) produced inhibition of IPSPs (yellow/red), which we call disinhibition, around the stimulation site (small dot), followed by a disinhibition in the output layers SP/SO. Note, later (⬎190 ms), DAGO produced inhibition of late depolarization in SLM (blue), while simultaneously disinhibiting activity (yellow/ red) in output layers (SO/SP). C: normalization of the DAGOinduced inhibition of IPSPs [(DAGO ⫺ Control)/Control]. Ci: note, DAGO inhibited IPSPs almost equivalently in all layers. For stimulation in SLM, amount of disinhibition was not measured due to overlapping depolarizing event. Scale bars: vertical 13% of Control, horizontal 50 ms (Cii–Civ). Histograms of DAGO-induced inhibition of IPSPs in different anatomical layers, expressed as a percentage of control IPSPs [100 ⫻ (DAGO ⫺ Control)/Control]. Histograms include data from all 3 stimulation sites (SLM, SR, SO). DAGOinduced inhibition of 1st IPSP amplitude (Ciii), 2nd IPSP amplitude (Civ), and total IPSP area (Cii) showed no significant difference between anatomical layers [P ⬎ 0.20 for all stimulation sites and all layers, 1-way ANOVA, n ⫽ 30 (SO, SP, SR), n ⫽ 20 (SLM)]. D: pseudo-color plot of normalized DAGO-induced inhibition of IPSPs. Normalized change in IPSPs shows DAGO-induced inhibition (red) of IPSP occurred uniformly throughout layers SR, SP, and SO. Relative amount of disinhibition occurring in SLM could not be judged in slices stimulated in SLM because of overlapping late depolarizing event. Later in recording, inhibition of depolarizing event in SLM occurred simultaneously with a continuing disinhibition in output layers (SP, SO).

1946

A. R. MCQUISTON AND P. SAGGAU

J Neurophysiol • VOL

have been shown to be located (Drake and Milner 1999). Thus it is possible that MOR activation produces a significant disinhibition in the dendritic layers that is not discernable from this previous electrophysiological study (Svoboda et al. 1999). This is consistent with more recent anatomical studies. MORs appear to be equivalently expressed on interneuron profiles (soma, axon or dendrite) that innervate the perisomatic region and the distal dendrites of pyramidal cells, whereas interneurons that selectively innervate other interneurons showed few cells expressing MOR (Drake and Milner 2002). This study (Drake and Milner 2002) did not examine the possibility that MOR is also located on interneurons that project to the proximal dendrites of pyramidal cells; however, Svoboda et al. (1999) showed that nearly half of these proximal dendritically projecting interneurons were hyperpolarized by MOR activation. From their own studies, Drake and Milner (2002) have suggested that MORs are expressed on heterogeneous groups of interneurons and likely have a more complicated effect on the neural network, including disinhibiting excitatory inputs onto CA1 pyramidal cell distal dendrites. Our findings are consistent with this (Drake and Milner 2002) and show that MOR inhibits GABAergic synaptic transmission in all layers of CA1. This suggests that MOR is functionally expressed on the terminals of interneuron subsets that project to all somatodendritic regions of CA1 pyramidal cells, and that MOR activation can influence all inputs to CA1 pyramidal neurons, including integration within pyramidal cell dendrites, as well as influencing the output of pyramidal cells. Opioid receptors expressed in the hippocampus may contribute to forming associations between environmental cues and drug intake (Corrigall and Linesman 1988; Olmstead and Franklin 1997a; Self and Stein 1993; Stevens et al. 1991; but see Olmstead and Franklin 1997b). Furthermore, opioids have been shown to alter synaptic plasticity and network oscillations in CA1 (Faulkner et al. 1998, 1999; Mansouri et al. 1997, 1999; Pu et al. 2002; Wagner et al. 2001; Whittington et al. 1998). Alteration of synaptic plasticity may affect the formation of associations between environment cues and drug intake, and the disruption of network oscillations may affect normal cognitive processing during drug use, as these oscillations have been correlated with perceptual tasks and attentive states. Our data suggest that activation of MORs in CA1 facilitates excitatory activity within the network, especially between distantly separated portions of the hippocampal network. This may facilitate interactions between spatially separated synaptic inputs in the same pyramidal neuron and contribute to the network changes involved the formation of associations made by the hippocampus during drug intake. The authors thank K. Bell and T. Hoogland for comments on the manuscript. DISCLOSURES

This work was supported by National Institute of Neurological Disorders and Stroke Grant NS-33147 and National Science Foundation Grant 0099545 to P. Saggau. REFERENCES Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf ME, and Elde R. Distribution and targeting of a ␮-opioid receptor (MOR1) in brain and spinal-cord. J Neurosci 15: 3328 –3341, 1995.

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

Lambert et al. 1991; Michelson and Wong 1991; Perkins 1999; Perkins and Wong 1996; Staley et al. 1995; Taira et al. 1997) that in turn permitted the opening of NMDA receptors (Staley et al. 1995). However, sometimes a slow depolarization persisted in the presence of glutamate and GABAA receptor antagonists, suggesting another unknown contributor to the delayed depolarization. Interestingly, in contrast to the MOR augmentation of the EPSP-like excitatory events, MOR activation inhibited this delayed depolarization in SLM, and this was shown to be due to an affect on the GABAA component of the delayed depolarization. This occurred at the same time other layers were disinhibited, suggesting that MOR activity can produce opposing effects in different layers of CA1 under certain conditions—more specifically, MOR activation can produce a late inhibition of excitatory activity in SLM while the other layers are being disinhibited. In addition to augmenting excitatory inputs to CA1, MOR activation facilitated the propagation of excitatory activity away from the site of initiation. The simplest explanation for this facilitation is based on a passive electrical cable model of reduced inhibition in all layers of CA1. As the excitatory event propagates through the network, there is reduced inhibition in each anatomical layer of the network. At locations distal to the site of stimulation, the excitation is augmented by the reduced inhibition at the stimulation site and also by the reduced inhibition at all points along the neuronal network through which the signal has propagated. This results in a proportionately larger increase in excitation at distal sites due to the summed points of disinhibition. However, we cannot discount the possible contribution of voltage-dependent ion channels or action potentials to the observed increase in excitability in the different layers of CA1. Voltage-dependent ion channels are found throughout the somato-dendritic axis of CA1 pyramidal neurons (for reviews, see Hausser et al. 2000; Magee 2000; Magee et al. 1998; Reyes 2001). During MOR activation, the augmented excitatory events may activate these voltage-dependent sodium or calcium channels, boosting the excitation amplitudes more at these distal sites than at the site of stimulation (Gillessen and Alzheimer 1997; Lipowsky et al. 1996). Even though the exact mechanisms contributing to the facilitation of the propagation of excitatory events cannot be determined from these experiments, it can be concluded that MOR activation augments excitatory events from all inputs and facilitates the propagation of excitatory activity between layers of CA1. Under the conditions of these investigations, the activation of MORs augments CA1 excitatory inputs and facilitates the propagation of excitatory activity in CA1 pyramidal cells by inhibiting GABAergic synaptic transmission onto GABAA receptors. Furthermore, our studies suggest that MOR activation controls excitatory activity by inhibiting IPSPs in all layers of CA1 by an equal amount. These findings differ somewhat from the studies of Svoboda et al. (1999) who hypothesized that the primary function of MORs was to inhibit the output of the pyramidal cells, with a less significant effect on their inputs or dendritic integration. However, their study revealed that MOR-induced hyperpolarizations were also observed in a significant number of interneurons projecting to the dendritic layers (SR, 50%; SLM, 43%; SO, 38%) in addition to interneurons projecting to pyramidal cell somata (SP, 91%) (Svoboda et al. 1999). Furthermore, these studies do not exclude the possibility that MORs may be preferentially expressed on the terminals of some interneurons, where MORs

MOR MODULATION OF PROPAGATION OF EXCITATION IN CA1

J Neurophysiol • VOL

Lupica CR, Proctor WR, and Dunwiddie TV. Dissociation of mu-opioid and delta-opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus invitro. Brain Res 593: 226 –238, 1992. Lynch GS, Jensen RA, McGaugh JL, Davila K, and Oliver MW. Effects of enkephalin, morphine, and naloxone on the electrical-activity of the in vitro hippocampal slice preparation. Exp Neurol 71: 527–540, 1981. Madison DV and Nicoll RA. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J Physiol 398: 123–130, 1988. Magee J, Hoffman D, Colbert C, and Johnston D. Electrical and calcium signaling in dendrites of hippocampal pyramidal neurons. Annu Rev Physiol 60: 327–346, 1998. Magee JC. Dendritic integration of excitatory synaptic input. Nature Rev Neurosci 1: 181–190, 2000. Mansour A, Fox CA, Burke S, Akil H, and Watson SJ. Immunohistochemical localization of the cloned mu-opioid receptor in the rat CNS. J Chem Neuroanat 8: 283–305, 1995. Mansour A, Khachaturian H, Lewis ME, Akil H, and Watson SJ. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445–2464, 1987. Mansouri FA, Motamedi F, and Fathollahi Y. Chronic in vivo morphine administration facilitates primed- bursts-induced long-term potentiation of Schaffer collateral- CA1 synapses in hippocampal slices in vitro. Brain Res 815: 419 – 423, 1999. Mansouri FA, Motamedi F, Fathollahi Y, Atapour N, and Semnanian S. Augmentation of LTP induced by Primed-Bursts tetanic stimulation in hippocampal CA1 area of morphine dependent rats. Brain Res 769: 119 – 124, 1997. Martinez JL Jr, Jensen RA, Creager R, Veliquette J, Messing RB, McGaugh JL, and Lynch G. Selective effects of enkephalin on electrical activity of the in vitro hippocampal slice. Behav Neural Biol 26: 128 –131, 1979. Masukawa LM and Prince DA. Enkephalin inhibition of inhibitory input to CA1 and CA3 pyramidal neurons in the hippocampus. Brain Res 249: 271–280, 1982. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, LeMeur M, Dolle P, Tzavara E, Hanoune J, Roques BP, and Kieffer BL. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819 – 823, 1996. McLean S, Rothman RB, Jacobson AE, Rice KC, and Herkenham M. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol 255: 497–510, 1987. Michelson HB and Wong RKS. Excitatory synaptic responses mediated by GABAA receptors in the hippocampus. Science 253: 1420 –1423, 1991. Miles R, Toth K, Gulyas AI, Hajos N, and Freund TF. Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16: 815– 823, 1996. Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, and Koob GF. Effect of antagonists selective for mu-opioid, delta-opioid and kappa-opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265: 1245–1252, 1993. Neumaier JF, Mailheau S, and Chavkin C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J Pharmacol Exp Ther 244: 564 –570, 1988. Nicoll RA, Alger BE, and Jahr CE. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287: 22–25, 1980. Olmstead MC and Franklin KBJ. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav Neurosci 111: 1313–1323, 1997a. Olmstead MC and Franklin KBJ. The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites. Behav Neurosci 111: 1324 –1334, 1997b. Pang K and Rose GM. Differential-effects of methionine-5-enkephalin on hippocampal pyramidal cells and interneurons. Neuropharmacology 28: 1175–1181, 1989. Perkins KL. Cl- accumulation does not account for the depolarizing phase of the synaptic GABA response in hippocampal pyramidal cells. J Neurophysiol 82: 768 –777, 1999. Perkins KL and Wong RK. Ionic basis of the postsynaptic depolarizing GABA response in hippocampal pyramidal cells. J Neurophysiol 76: 3886 – 3894, 1996.

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

Bausch SB and Chavkin C. Colocalization of mu and delta opioid receptors with GABA, parvalbumin, and a G-protein-coupled inwardly rectifying potassium channel (GIRK1) in the rodent brain. Analgesia 1: 282–285, 1995. Capogna M, Gahwiler BH, and Thompson SM. Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in-vitro. J Physiol 470: 539 –558, 1993. Cobb SR, Manuel NA, Morton RA, Gill CH, Collingridge GL, and Davies CH. Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampus. Neuropharmacology 38: 1723–1732, 1999. Cohen GA, Doze VA, and Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 9: 325–335, 1992. Colom LV and Saggau P. Spontaneous interictal-like activity originates in multiple areas of the CA2-CA3 region of hippocampal slices. J Neurophysiol 71: 1574 –1584, 1994. Corrigall WA and Linseman MA. A specific effect of morphine on evoked activity in the rat hippocampal slice. Brain Res 192: 227–238, 1980. Corrigall WA and Linseman MA. Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav 30: 787–789, 1988. Crain BJ, Chang KJ, and McNamara JO. Quantitative autoradiographic analysis of mu and delta opioid binding sites in the rat hippocampal formation. J Comp Neurol 246: 170 –180, 1986. Deadwyler SA and Robinson JH. Effects of morphine on hippocampal cells recorded invitro. Brain Res Bull 4: 609 – 613, 1979. Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. J Neurosci 1: 1022–1035, 1981. Drake CT and Milner TA. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res 849: 203–215, 1999. Drake CT and Milner TA. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12: 119 –136, 2002. Faulkner HJ, Traub RD, and Whittington MA. Disruption of synchronous gamma oscillations in the rat hippocampal slice: a common mechanism of anaesthetic drug action. Brit J Pharmacol 125: 483– 492, 1998. Faulkner HJ, Traub RD, and Whittington MA. Anaesthetic/amnesic agents disrupt beta frequency oscillations associated with potentiation of excitatory synaptic potentials in the rat hippocampal slice. Brit J Pharmacol 128: 1813–1825, 1999. French ED and Siggins GR. An iontophoretic survey of opioid peptide actions in the rat limbic system - in search of opiate epileptogenic mechanisms. Regul Pept 1: 127–146, 1980. Freund TF and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6: 347– 470, 1996. Gillessen T and Alzheimer C. Amplification of EPSPs by low Ni2⫹- and amiloride-sensitive Ca2⫹ channels in apical dendrites of rat CA1 pyramidal neurons. J Neurophysiol 77: 1639 –1643, 1997. Grover LM, Lambert NA, Schwartzkroin PA, and Teyler TJ. Role of HCO3⫺ ions in depolarizing GABAA receptor-mediated responses in pyramidal cells of rat hippocampus. J Neurophysiol 69: 1541–1555, 1993. Haas HL and Ryall RW. Is excitation by enkephalins of hippocampalneurons in the rat due to presynaptic facilitation or to disinhibition? J Physiol 308: 315–330, 1980. Hausser M, Spruston N, and Stuart GJ. Diversity and dynamics of dendritic signaling. Science 290: 739 –744, 2000. Jin W, Zhang RJ, and Wu JY. Voltage-sensitive dye imaging of population neuronal activity in cortical tissue. J Neurosci Methods 115: 13–27, 2002. Lambert NA, Borroni AM, Grover LM, and Teyler TJ. Hyperpolarizing and depolarizing GABAA receptor-mediated dendritic inhibition in area CA1 of the rat hippocampus. J Neurophysiol 66: 1538 –1548, 1991. Lambert NA, Harrison NL, and Teyler TJ. Evidence for ␮-opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neurosci Lett 124: 101–104, 1991. Lee HK, Dunwiddie T, and Hoffer B. Electro-physiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. 2. Effects on interneuron excitability. Brain Res 184: 331–342, 1980. Lipowsky R, Gillessen T, and Alzheimer C. Dendritic Na⫹ channels amplify EPSPs in hippocampal CA1 pyramidal cells. J Neurophysiol 76: 2181–2191, 1996. Lupica CR. Delta-enkephalin and mu-enkephalin inhibit spontaneous GABAmediated IPSCs via a cyclic-AMP-independent mechanism in the rat hippocampus. J Neurosci 15: 737–749, 1995.

1947

1948

A. R. MCQUISTON AND P. SAGGAU

J Neurophysiol • VOL

Svoboda KR, Adams CE, and Lupica CR. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J Neurosci 19: 85–95, 1999. Svoboda KR and Lupica CR. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J Neurosci 18: 7084 –7098, 1998. Swearengen E and Chavkin C. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology 28: 689 – 697, 1989. Taira T, Lamsa K, and Kaila K. Posttetanic excitation mediated by GABA(A) receptors in rat CA1 pyramidal neurons. J Neurophysiol 77: 2213–2218, 1997. Wagner JJ, Etemad LR, and Thompson AM. Opioid-mediated facilitation of long-term depression in rat hippocampus. J Pharmacol Exp Ther 296: 776 –781, 2001. Whittington MA, Traub RD, Faulkner HJ, Jefferys JGR, and Chettiar K. Morphine disrupts long-range synchrony of gamma oscillations in hippocampal slices. Proc Natl Acad Sci USA 95: 5807–5811, 1998. Wimpey TL and Chavkin C. Opioids activate both an inward rectifier and a novel voltage- gated potassium conductance in the hippocampal-formation. Neuron 6: 281–289, 1991. Zieglgansberger W, French ED, Siggins GR, and Bloom FE. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205: 415– 417, 1979. Zochowski M, Wachowiak M, Falk CX, Cohen LB, Lam YW, Antic S, and Zecevic D. Imaging membrane potential with voltage-sensitive dyes. Biol Bull 198: 1–21, 2000.

90 • SEPTEMBER 2003 •

www.jn.org

Downloaded from http://jn.physiology.org/ by guest on May 30, 2013

Pu L, Bao GB, Xu NJ, Ma L, and Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 22: 1914 –1921, 2002. Rekling JC. Effects of met-enkephalin on GABAergic spontaneous miniature IPSPS in organotypic slice cultures of the rat hippocampus. J Neurosci 13: 1954 –1964, 1993. Reyes A. Influence of dendritic conductances on the input-output properties of neurons. Annu Rev Neurosci 24: 653– 675, 2001. Robinson JH and Deadwyler SA. Intracellular correlates of morphine excitation in the hippocampal slice preparation. Brain Res 224: 375–387, 1981. Self DW and Stein L. Pertussis toxin attenuates intracranial morphine selfadministration. Pharmacol Biochem Behav 46: 689 – 695, 1993. Siggins GR and Zieglgansberger W. Morphine and opioid-peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells-in vitro without alteration of membrane-potential. Proc Nat Acad Sci USA 78: 5235– 5239, 1981. Sinha SR, Patel SS, and Saggau P. Simultaneous optical-recording of evoked and spontaneous transients of membrane-potential and intracellular calciumconcentration with high spatiotemporal resolution. J Neurosci Methods 60: 49 – 60, 1995. Sinha SR and Saggau P. Optical recording from populations of neurons in brain slices. In: Modern Techniques in Neuroscience Research, edited by Johanson H and Windhorst U. Heidelberg, Germany: Springer Verlag, 1999. Staley KJ, Soldo BL, and Proctor WR. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269: 977–981, 1995. Stevens KE, Shiotsu G, and Stein L. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region. Brain Res 545: 8 –16, 1991.